Your browser doesn't support javascript.
loading
Adjuvant hormonal therapy for early breast cancer: an epidemiologic study of medication adherence.
Pourcelot, Charlotte; Orillard, Emeline; Nallet, Gilles; Dirand, Camille; Billion-Rey, François; Barbier, Garance; Chouk, Sarah; Limat, Samuel; Montcuquet, Philippe; Henriques, Julie; Paget-Bailly, Sophie; Anota, Amélie; Chaigneau, Loïc; Nerich, Virginie.
Afiliación
  • Pourcelot C; Department of Pharmacy, Besançon University Hospital, Boulevard Fleming, 25030, Besançon Cedex, France.
  • Orillard E; Department of Medical Oncology, Besançon University Hospital, Boulevard Fleming, 25030, Besançon Cedex, France.
  • Nallet G; Federative Regional Institute for Cancer of Franche-Comté, Boulevard Fleming, 25030, Besançon Cedex, France.
  • Dirand C; ONCOLIE Network of Cancer, Boulevard Fleming, 25030, Besançon Cedex, France.
  • Billion-Rey F; Department of Pharmacy, Besançon University Hospital, Boulevard Fleming, 25030, Besançon Cedex, France.
  • Barbier G; Department of Pharmacy, Lons-le-Saunier Hospital, Rue du Dr Jean Michel, 39000, Lons Le Saunier, France.
  • Chouk S; Department of Pharmacy, Besançon University Hospital, Boulevard Fleming, 25030, Besançon Cedex, France.
  • Limat S; Department of Pharmacy, Besançon University Hospital, Boulevard Fleming, 25030, Besançon Cedex, France.
  • Montcuquet P; Department of Pharmacy, Besançon University Hospital, Boulevard Fleming, 25030, Besançon Cedex, France.
  • Henriques J; University of Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Boulevard Fleming, 25020, Besançon Cedex, France.
  • Paget-Bailly S; Department of Medical Oncology, Besançon University Hospital, Boulevard Fleming, 25030, Besançon Cedex, France.
  • Anota A; University of Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Boulevard Fleming, 25020, Besançon Cedex, France.
  • Chaigneau L; Besançon University Hospital, Methodological and Quality of Life in Cancerology Unit, University of Bourgogne Franche-Comté, Boulevard Fleming, 25000, Besançon, France.
  • Nerich V; University of Bourgogne Franche-Comté, INSERM, EFS BFC, UMR1098, Interactions hôte-greffon-tumeur - Ingénierie Cellulaire et Génique, Boulevard Fleming, 25020, Besançon Cedex, France.
Breast Cancer Res Treat ; 169(1): 153-162, 2018 May.
Article en En | MEDLINE | ID: mdl-29362956
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Tamoxifeno / Neoplasias de la Mama / Antineoplásicos Hormonales / Cumplimiento de la Medicación Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2018 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Tamoxifeno / Neoplasias de la Mama / Antineoplásicos Hormonales / Cumplimiento de la Medicación Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2018 Tipo del documento: Article País de afiliación: Francia